MoonLake Immunotherapeutics
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MLTX | LKFT | NKTR | CRVS | 8SJ.F | ALMS | |
|---|---|---|---|---|---|---|
| Market cap | 983.83M | 2.25B | 1.31B | 889.16M | 1.84B | 847.80M |
| P/E (TTM) | — | 3.2 | — | — | — | — |
| Forward P/E | -3.5 | -28.6 | -3.7 | -9.9 | — | -2.3 |
| Price/book | 2.7 | 12.2 | 1.5 | 3.9 | 2.4 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +10.48% | +7.56% | −30.41% | +35.17% | −40.07% | +42.23% |
| Today | −1.20% | +6.03% | +1.91% | +7.53% | +1.70% | +0.77% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MLTX news ›MoonLake Immunotherapeutics Could Win FDA Approval for Sonelokimab by Year-End 2027, Wedbush Says
MoonLake Immunotherapeutics could receive US Food and Drug Administration approval for sonelokimab as a treatment for hidradenitis suppurativa by year-end 2027, with the completed BLA submission... Biotechnology & Medical Research MoonLake…
MoonLake Immunotherapeutics Makes Case for Sonelokimab Approval, RBC Says
MoonLake Immunotherapeutics made a reasonably solid case for the approvability of sonelokimab as a treatment for hidradenitis suppurativa, RBC Capital Markets said in a Friday note. The company... Biotechnology & Medical Research MoonLake…
What's Going On with MoonLake Immunotherapeutics Stock on Thursday?
MoonLake Immunotherapeutics MLTX stock is trading higher on Thursday with a session volume of 4.20 million compared to the average volume of 1.494 million, according to Benzinga Pro data. The jump comes in reaction to topline data from…
Alpha Tau Medical’s (DRTS) Buy Rating Reiterated at HC Wainwright
Posted by Danessa Lincoln on Oct 23rd, 2026 HC Wainwright reiterated their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS – Free Report) in a report released on Tuesday morning, Marketbeat reports. HC Wainwright currently has a…
MoonLake’s sonelokimab faces regulatory, commercial tests, RBC says
MoonLake (MLTX) argues sonelokimab could win FDA acceptance for HS; RBC sees a near-term catalyst but urges caution on approval odds. janiecbros/E+ via Getty Images MoonLake Immunotherapeutics (MLTX) presented a reasonably convincing case…
HC Wainwright & Co. reiterates Buy rating on Harmony Biosciences Hldgs, $55 price target
HC Wainwright & Co. reiterated their Buy rating on Harmony Biosciences Hldgs's stock with a price target of $55.00. The price target implies an upside of 43.9% from the Oct 12 close of $38.23. Strong Leadership Experience: The new CEO,…
Lake Street Initiates Coverage on Envoy Medical With Buy Rating, $2.50 Price Target
... Advanced Medical Equipment & Technology Lake Street Initiates Coverage on Envoy Medical With Buy Rating, $2.50 Price Target Published on 10/06/2026 at 08:25 am EDT
Autolus Therapeutics (AUTL) Receives a Buy from Wells Fargo
In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus Therapeutics, with a price target of $5.00. The company’... In a report released on October 2, from Wells Fargo maintained a Buy rating on Autolus…
Analysts Are Bullish on These Healthcare Stocks: Alkermes (ALKS), MoonLake Immunotherapeutics (MLTX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alkermes (ALKS), MoonLake Immunotherapeutics (MLTX) and Maze Therapeutics, Inc. (MAZE) with bullish sentiments. In a report released today, Paul…
MoonLake Immunotherapeutics (NASDAQ:MLTX) Earns “Buy” Rating from HC Wainwright
Posted by Danessa Lincoln on Oct 6th, 2026 MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Monday, Marketbeat.com reports. They…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com5
- marketscreener.com3
- markets.businessinsider.com2
- tradingview.com2
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.